InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Young David, Chief Executive Officer. Insider active across 1 companies, notably Processa Pharmaceuticals, Inc.. In total, 4 filings have been logged. Total volume traded: €129k. The latest transaction was filed on 23 June 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
7,601 shares
Common Stock
SEC:0001567619-21-014741·
7,601 shares
Common Stock
SEC:0001567619-21-014741:0·
€64,28810,000 shares@ €6.42880.99% mcap100.0% of flow
Common Stock
SEC:0001567619-21-012540·
Ideal exit: 20 Mar 2022 (T+270)
€64,28810,000 shares@ €6.42880.99% mcap50.0% of flow
Common Stock
SEC:0001567619-21-012540:0·
Ideal exit: 20 Mar 2022 (T+270)
4 of 4 declarations
About Young David
David Young is the Chief Executive Officer of Processa Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company. His leadership and expertise in the pharmaceutical sector are essential in guiding Processa Pharmaceuticals, Inc. towards its growth objectives.
